Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Products>This Product
  Products


S-334 Fast Steering Mirror Platform

Product Description
S-334 tip/tilt platforms are fast and compact units, providing precise angular movements of a mirror around two orthogonal axes. The tip/tilt range is 50 mrad with sub-µrad resolution. In closed-loop operation, highest stability and accuracy is available.Huge Tip/Tilt Ranges with Excellent Motion Characteristics. The novel lever design combines the exceptional large tip/tilt range of 3° (mechanical tilt, which is equivalent to 100 mrad optical beam deflection) with the high resonant frequency of 1.0 kHz (including the mirror). These parameters make the system unique in the market of high-speed, long-range scanners.

Sub-Microradian Resolution and Stable Positioning
The S-334 provides sub-microradian resolution. When operated in closed-loop mode, it offers absolute position control and high linearity of typically under ±0.25% over the entire travel range. This is achieved by high-resolution, full-bridge strain gauge sensors (SGS), calibrated specifically for each unit with the control electronics.

Recommended control electronics: the E-500 system, configured for tip/tilt mirrors with E-501.00 chassis, E-503.00S amplifier and E-509.S3S servo-controller.

  • Tilt Range up to 50 mrad (3°) in 2 Fixed Orthogonal Axes
  • 1.0 kHz Resonant Frequency with Mirror
  • Closed-Loop Version
  • For Mirrors up to 12.5 mm (0.5 ") Diameter
  • Common Pivot Point
  • Sensor Configuration for Excellent Temperature Stability
Product S-334 Fast Steering Mirror Platform
Company Physik Instrumente - Products
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Physik Instrumente - Products
Auf der Römerstr. 1 D-76228 Karlsruhe Germany

Tel: +49 721 4846-0
Fax: +49 721 4846-1019
Email: info@pi.ws



Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!